UK: SALES OF PROZAC RAISE CONCERN

Article Abstract:

The rising sales of Prozac, the anti-depressant drug have caused concern among critics in the UK, who believe that it reveals a trend towards pharmaceutical-dependency. Prozac is prescribed to 3mn people per year in the UK, and worldwide sales amounted to US$ 2.6bn in 1999. At the same time, Prozac is welcome as an effective treatment for depression and could reduce the 4,000 deaths per year from this illness if prescribed even more widely.

Sales & consumption, Antidepressant Preparations, Health aspects, Product information, Eli Lilly and Co., Antidepressants, LLY, Prozac (Medication)

---

UK: GLAXOSMITHKLINE TO SPLIT INTO 8 UNITS

Article Abstract:

It has been revealed that GlaxoSmithKline, the UK based drugs giant to be created by the merger of Glaxo Wellcome and SmithKline Beecham, is to split its research group into eight units. It is hoped that this autonomous structure will promote innovation and flexibility among its staff. Each new unit is expected to be able to operate profitably and will compete for internal funds.

Organizational history, Pharmaceutical Preparations, Management, Brief Article, Glaxo Wellcome/ SmithKline Beecham

---

Similar abstracts:

• Abstracts: UK: RISE IN TB CASES CAUSES CONCERN. UK: AVANDIA TO HELP DIABETES CASES. UK: PROFILE THERAPEUTICS' NEW AAD SYSTEM
• Abstracts: UK: LACK OF FUNDING THREATENS BOWMAN PROJECT. UK: PRESSAC BUYS WH SMITH & SONS. UK: GLOBAL TELEMATICS FLOAT IS OFF
• Abstracts: UK: HSE WORRIED BY 20% RISE IN BUILDING DEATHS. UK: ALLEN TO DISPOSE OF HOUSEBUILDING ARM. In Brief: Bovis 'on offer'

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.